Paasa Logo
GenSight Biologics S.A. logo
SIGHTPARMarket closedOpens 9:00am CET

GenSight Biologics S.A.

€0.12Last updated
-€0.01 (6.97%)Past day
Timezone

GenSight Biologics S.A. (PAR: SIGHT) is trading at €0.12, about ₹13 at today's EUR/INR rate, as of 25 Sep 2026, 11:35 AM ET, down 6.97% today. Indian residents can buy GenSight Biologics from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:€0.13
Previous close:€0.13
Volume:2.69M

Today's low

€0.12

Today's high

€0.14

52 week low

€0.08

52 week high

€0.24

SIGHT opened at €0.13, closed previously at €0.13, and has traded between €0.08 and €0.24 over the past 52 weeks.

About

GenSight Biologics S.A. is a clinical-stage biotechnology firm focused on identifying, advancing, and commercializing medical interventions for severe mitochondrial and neurodegenerative conditions affecting both the eyes and the central nervous system. Their therapeutic development leverages cutting-edge gene therapy platforms, specifically those involving mitochondrial targeting sequences and optogenetics. The company's leading drug candidate, LUMEVOQ (GS010), a recombinant AAV2-based gene therapy, is currently undergoing Phase III clinical evaluation for treating Leber hereditary optic neuropathy (LHON) caused by a specific ND4 gene mutation. Another significant program, GS030, is engaged in Phase I/II clinical trials for retinitis pigmentosa and is also in the preclinical phase for dry age-related macular degeneration. Furthermore, GenSight Biologics is developing additional preclinical-stage programs aimed at various ophthalmic and neurodegenerative disorders. The company was founded in 2012 and maintains its headquarters in Paris, France.

Country
FR
CEO
Laurence Rodriguez
Exchange listed on
PAR
Industry
Biotechnology
Base currency
EUR
Full Time Employees
13
Sector
Healthcare
IPO date
13/07/2016

Key statistics

Avg. volume

1.07M

Market cap

€20.02M

P/E Ratio

-1.51

Price-to-sales ratio

20016.40

Enterprise value

€30.46M

Free cash flow yield

-45.78%

Debt-to-equity ratio

-0.52

Return on equity

42.20%

ROIC

1515.43%

Beta

0.70

Dividend yield

0.00%

Last dividend

€0.00

Financial overview

Revenue

€1.00K

Earnings per share

-€0.08

Free cash flow

-€9.38M

Net profit margin

-1203600.00%

Gross margin

100.00%

EBITDA

-€11.24M

Revenue growth

-99.96%

Similar securities

This is not an investment recommendation

How to buy GenSight Biologics from India

Indian residents can buy GenSight Biologics shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to EUR.

  3. Search for GenSight Biologics and place an order

    Find GenSight Biologics by name or by its ticker, SIGHT, and choose an order type. GenSight Biologics trades 12:30 pm – 9:00 pm IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your GenSight Biologics position in EUR and INR. GenSight Biologics pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in GenSight Biologics from India

Trading and taxes when buying GenSight Biologics from India

Trading and limits

Trading hours
9:00 am – 5:30 pm CET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneGenSight Biologics does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained

Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

FAQs

Can Indian residents buy GenSight Biologics stock?

Yes. GenSight Biologics (SIGHT) has been listed on Euronext Paris since 2016, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to EUR. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

How much does one GenSight Biologics share cost in rupees?

One GenSight Biologics share is €0.12 — about ₹13 at an EUR/INR rate of 109.37 on 25 Sep 2026. Both the GenSight Biologics price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying GenSight Biologics from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

How are gains on GenSight Biologics shares taxed in India?

Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the EUR/INR rate on the purchase and the sale date, so the rupee move counts alongside the GenSight Biologics price. Paasa issues a capital-gains statement for your return.

Does GenSight Biologics pay a dividend?

No. GenSight Biologics does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade GenSight Biologics from India?

Euronext Paris trades 12:30 pm – 9:00 pm IST in Indian time. The window shifts to 1:30 pm – 10:00 pm IST when France is on standard time. Orders can only execute during that window.

Do I have to declare GenSight Biologics shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your GenSight Biologics holding, its cost and its closing value.

How do I sell GenSight Biologics and bring the money back to India?

You sell during market hours (12:30 pm – 9:00 pm IST) and the proceeds settle in EUR in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.

Does the rupee rate affect what I make on GenSight Biologics?

Yes. GenSight Biologics is priced in EUR, so your rupee outcome combines the EUR move with the EUR/INR move between the day you remit and the day you convert back. Both directions are reflected in the capital-gains statement Paasa issues.